Already registered? Need to register? Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

About the PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.
Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings
Why are new treatments needed?

Why are new
treatments needed?

Read more »
What are the benefits of PCSK9 inhibitors?

What are the benefits
of PCSK9 inhibitors?

Read more »
PCSK9 inhibitors in real world practice?

PCSK9 inhibitors in
real world practice?

Read more »
Most viewed
Most viewed

From the Editors

PCSK9 inhibitors in Acute Coronary SyndromesPCSK9 inhibitors in Acute Coronary SyndromesBaris Gencer

Despite best treatment, patients with ACS remain at high risk of recurrent events. Baris Gencer, Geneva University Hospitals, Switzerland, discusses the evidence for PCSK9 inhibitors in ACS, and potential mechanisms beyond LDL-C lowering.


Read the full article